Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1991 2
1992 1
1993 1
1999 1
2001 1
2007 4
2008 2
2010 4
2011 5
2012 1
2014 2
2015 3
2016 1
2017 2
2019 2
2023 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.
5-Fluorouracil-induced Tako-Tsubo-like syndrome.
Basselin C, Fontanges T, Descotes J, Chevalier P, Bui-Xuan B, Feinard G, Timour Q. Basselin C, et al. Among authors: fontanges t. Pharmacotherapy. 2011 Feb;31(2):226. doi: 10.1592/phco.31.2.226. Pharmacotherapy. 2011. PMID: 21275498
[Maintenance therapy for chronic hepatitis C].
Trépo C, Marion-Audibert AM, Samuel D, Guyader D, Fontanges T. Trépo C, et al. Among authors: fontanges t. Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 3):4S29-33. Gastroenterol Clin Biol. 2007. PMID: 17965632 Free article. Review. French.
Predictive Factors for HBsAg Loss in Chronic HBeAg-Negative Hepatitis B Virus Infection: Insights From a 5-Year French Cohort.
Causse X, Potier P, Valéry A, Labadie H, Macaigne G, Cadranel JF, Fontanges T, Mouna L, Roque-Afonso AM; PIBAC Study Group of Association Nationale des Hépato‐Gastroentérologues des Hôpitaux Généraux (ANGH). Causse X, et al. Among authors: fontanges t. J Viral Hepat. 2025 Jan;32(1):e14041. doi: 10.1111/jvh.14041. J Viral Hepat. 2025. PMID: 39673688 Free PMC article.
What are the outcomes for long-term survivors after esophagectomy ? - Evidence from a randomized controlled trial (FFCD9901).
Robb WB, Veziant J, Dahan L, Mornex F, Barbier E, D'Journo XB, Manfredi S, Boige V, Jary M, Christou N, Lepage C, Piessen G; FFCD, SFRO, UNICANCER, GERCOR and the FREGAT working group-FRENCH. Robb WB, et al. Eur J Surg Oncol. 2025 Jul;51(7):109736. doi: 10.1016/j.ejso.2025.109736. Epub 2025 Mar 6. Eur J Surg Oncol. 2025. PMID: 40120352 Free article. Clinical Trial.
Evaluation of the HBV liver reservoir with fine needle aspirates.
Testoni B, Roca Suarez AA, Battisti A, Plissonnier ML, Heil M, Fontanges T, Villeret F, Chouik Y, Levrero M, Gill U, Kennedy P, Zoulim F. Testoni B, et al. Among authors: fontanges t. JHEP Rep. 2023 Jul 11;5(10):100841. doi: 10.1016/j.jhepr.2023.100841. eCollection 2023 Oct. JHEP Rep. 2023. PMID: 37675272 Free PMC article.
Adenoma detection with blue-water infusion colonoscopy: a randomized trial.
Lesne A, Rouquette O, Touzet S, Petit-Laurent F, Tourlonias G, Pasquion A, Rivory J, Aguero Garcete G, Scanzi J, Chalumeau S, Chambon-Augoyard C, Moussata D, Leger-Nguyen F, Degeorges S, Chauvenet M, Fontanges T, Baubet S, Brulet P, Billioud C, Thimonier E, Stroeymeyt-Martin K, Hamel B, Graillot E, Cruiziat C, Scalone O, O'Brien M, Péré-Vergé D, Souquet JC, Phelip JM, Poincloux L, Poupon-Bourdy S, Denis A, Magaud L, Ponchon T, Pioche M. Lesne A, et al. Among authors: fontanges t. Endoscopy. 2017 Aug;49(8):765-775. doi: 10.1055/s-0043-105073. Epub 2017 Apr 11. Endoscopy. 2017. PMID: 28399611 Clinical Trial.
Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone.
Robb WB, Messager M, Dahan L, Mornex F, Maillard E, D'Journo XB, Triboulet JP, Bedenne L, Seitz JF, Mariette C; Fédération Francophone de Cancérologie Digestive; Société Française de Radiothérapie Oncologique; Union des Centres de Lutte Contre le Cancer; Groupe Coopérateur Multidisciplinaire en Oncologie; French EsoGAstric Tumour working group - Fédération de Recherche En Chirurgie. Robb WB, et al. Br J Surg. 2016 Jan;103(1):117-25. doi: 10.1002/bjs.9959. Epub 2015 Oct 29. Br J Surg. 2016. PMID: 26511668 Clinical Trial.
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial.
Merle P, Blanc JF, Phelip JM, Pelletier G, Bronowicki JP, Touchefeu Y, Pageaux G, Gerolami R, Habersetzer F, Nguyen-Khac E, Casadei-Gardini A, Borbath I, Tran A, Wege H, Saad AS, Colombo M, Abergel A, Richou C, Waked I, Yee NS, Molé A, Attali P, Le Boulicaut J, Vasseur B; RELIVE Investigators. Merle P, et al. Lancet Gastroenterol Hepatol. 2019 Jun;4(6):454-465. doi: 10.1016/S2468-1253(19)30040-8. Epub 2019 Apr 4. Lancet Gastroenterol Hepatol. 2019. PMID: 30954567 Free article. Clinical Trial.
35 results